Molecular interactions involving urokinase plasminogen activator (uPA), its receptor (uPAR) and its inhibitor, plasminogen activator inhibitor-1 (PAI-1), as new targets for tumour therapy

By Frankenne F.   Noel A.   Bajou K.   Sounni N.   Goffin F.   Masson V.   Munaut C.   Remacle A.   Foidart J.  

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 3, 1999-09 ,pp. : 469-481

Informa Healthcare

Access to resources Recommend Favorite

Proteome Analysis of Formalin-Fixed Paraffin-Embedded Tissues from a Primary Gastric Melanoma and its Meningeal Metastasis: A Case Report

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 3, 2014-02 ,pp. : 382-387

Bentham Science Publishers

Access to resources Recommend Favorite

Predictive Performance of the `Minto' Remifentanil Pharmacokinetic Parameter Set in Morbidly Obese Patients Ensuing from a New Method for Calculating Lean Body Mass

By >  

Clinical Pharmacokinetics, Vol. 49, Iss. 2, 2010-02 ,pp. : 131-139

Adis International

Access to resources Recommend Favorite

Angiogenesis: New Opportunities and Solutions for Drug Development. Predictive markers for antiangiogenic drugs

By Gerber Hans-Peter  

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 12, 2003-12 ,pp. : 2001-2004

Informa Healthcare

Access to resources Recommend Favorite

Prognostic and Predictive Markers in Colorectal Cancer - The Role of New Genomic Technologies

By  

Current Pharmacogenomics, Vol. 5, Iss. 4, 2007-12 ,pp. : 255-261

Bentham Science Publishers

Access to resources Recommend Favorite